• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [17290 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: considerations relating to the adoption of the learning health-care system approach, the reflective approach, and audit and feedback in the context of managing chronic diseases and multimorbid states]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Guidelines and standards: respiratory multiplex NAAT (8 or more targets)]
2019     NIHR Health Services and Delivery Research programme Developing a reporting guideline to improve meta-ethnography in health research: the eMERGe mixed-methods study
2019     NIHR Health Services and Delivery Research programme Innovation to enhance health in care homes and evaluation of tools for measuring outcomes of care: rapid evidence synthesis
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: use of rifapentine in the treatment of latent tuberculosis infection]
2019     NIHR Health Services and Delivery Research programme Digital and online symptom checkers and assessment services for urgent care to inform a new digital platform: a systematic review
2019     NIHR Health Services and Delivery Research programme Improving care for women and girls who have undergone female genital mutilation/cutting: qualitative systematic reviews
2019     NIHR Health Services and Delivery Research programme Multicomponent hospital-led interventions to reduce hospital stay for older adults following elective surgery: a systematic review
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: use of extracorporeal membrane oxygenation (ECMO) in adults in Quebec]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: use of linear accelerators with on-board magnetic resonance imaging (MRI) for real-time MRI-guided radiation therapy treatments]
2018     NIHR Health Technology Assessment programme Behavioural activation versus guided self-help for depression in adults with learning disabilities: the BeatIt RCT
2018     NIHR Health Technology Assessment programme Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: systematic reviews and economic evaluation
2018     Center for Evidence-based Practice (CEP) Update: Best practices for central venous catheter removal
2018     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Sofosbuvir (hepatitis C in adolescents) - benefit assessment according to §35a Social Code Book V]
2018     NIHR Health Technology Assessment programme Pharmacological and non-pharmacological interventions for non-respiratory sleep disturbance in children with neurodisabilities: a systematic review
2018     Center for Evidence-based Practice (CEP) Point-of Care Ultrasound for Acute Respiratory Distress
2018     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cabozantinib (renal cell carcinoma) - benefit assessment according to §35a Social Code Book V]
2018     NIHR Health Technology Assessment programme Brain and spinal stimulation therapies for phantom limb pain: a systematic review
2018     Center for Evidence-based Practice (CEP) Monitoring of Anticoagulation in Patients on Extracorporeal Membrane Oxygenation
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge on organizational models for intensive care units]
2018     NIHR Health Technology Assessment programme Assessing prognosis and prediction of treatment response in early rheumatoid arthritis: systematic reviews
2018     Center for Evidence-based Practice (CEP) Transjugular Intrahepatic Portosystemic Shunts for Patients with Acute Variceal Bleeding
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Guidelines and standards, English version updated in June 2020: requirements relating to the institutions responsible for the operation of acute healthcare facilities designated within the Quebec trauma network]
2018     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Obinutuzumab (non-pretreated advanced follicular lymphoma) - assessment according to §35a (1), sentence 11, Social Code Book V]
2018     NIHR Health Technology Assessment programme Bariatric surgery, lifestyle interventions and orlistat for severe obesity: the REBALANCE mixed-methods systematic review and economic evaluation
2018     Center for Evidence-based Practice (CEP) Update: Anticoagulation Management in Paracentesis and Thoracentesis
2018     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Midostaurin (acute myeloid leukaemia) - assessment according to §35a (1), sentence 11, Social Code Book V]
2018     NIHR Health Technology Assessment programme Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation
2018     Center for Evidence-based Practice (CEP) Home Administration of Intravenous Immunoglobulin
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: best practices for runaway prevention and intervention for youths living in rehabilitation centres for young persons with adjustment problems]
2018     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Telotristat ethyl (carcinoid syndrome diarrhoea) - benefit assessment according to §35a (1), sentence 11, Social Code Book V]
2018     NIHR Health Technology Assessment programme Contrast-enhanced ultrasound and/or colour duplex ultrasound for surveillance after endovascular abdominal aortic aneurysm repair: a systematic review and economic evaluation
2018     Center for Evidence-based Practice (CEP) Using Patient Generated Health Data in an Electronic Health Record
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: national and international practices in the organization of rehabilitative care for adults with permanent or temporary motor disabilities]
2018     Center for Evidence-based Practice (CEP) Management of Post-Biopsy Renal Bleeding
2018     Center for Evidence-based Practice (CEP) Location of Implanted Ports for Chemotherapy
2018     Center for Evidence-based Practice (CEP) Best Practices for Treating Acute/Severe Hyperkalemia in the Hospital Setting
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: living environment quality in long-term care facilities for dependent seniors]
2018     Center for Evidence-based Practice (CEP) Guidelines for Electrocardiography on Arrival to the Emergency Department
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: regulation of private congregate living facilities for the elderly]
2018     Center for Evidence-based Practice (CEP) Guidelines for Management of Acute Hydronephrosis
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: ministerial standards of access, quality, continuity, efficiency and effectiveness of the service d’intervention de crise dans le milieu 24/7]
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Dropouts in Psychotherapy. Part I: Predictors, theories and models to explain and recommend courses of action to avoid discontinuation of therapy. Part II: "Overview of Reviews" on dropouts in psychotherapy
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal use guide: herpes simplex eye disease]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal use guide: blepharitis]
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Options to identify inappropriate use of MRI, Part 3
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: islet transplantation in patients with unstable type I diabetes]
2018     NIHR Public Health Research (PHR) programme Child food insecurity in the UK: a rapid review
2018     Norwegian Institute of Public Health (NIPH) Therapist-supported internet therapy for mental disorders – a health technology assessment
2018     Adelaide Health Technology Assessment (AHTA) Extended half-life clotting factor concentrates for the treatment of haemophilia A and B
2018     Adelaide Health Technology Assessment (AHTA) Heritable mutations which increase risk in colorectal and endometrial cancer
2018     Adelaide Health Technology Assessment (AHTA) Anti-Mullerian Hormone (AMH) testing for female patients who will or have received gonadotoxic treatment
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Osimertinib (Tagrisso®) for the initial treatment of EGFR-mutated advanced non–small-cell lung cancer (NSCLC)
2018     Norwegian Institute of Public Health (NIPH) EXOGEN™ in the treatment of non-union fractures. A single technology assessment
2018     Norwegian Institute of Public Health (NIPH) Effectiveness and safety of nitrous oxide as sedation regimen in children – an HTA
2018     Norwegian Institute of Public Health (NIPH) Autologous hematopoietic stem cell transplantation (AHSCT) for Diffuse Systemic Sclerosis. Health Technology Assessment
2018     Norwegian Institute of Public Health (NIPH) The MicraTM Transcatheter Pacing System, a leadless pacemaker, in patients indicated for single-chamber ventricular pacemaker implantation: A single technology assessment
2018     Norwegian Institute of Public Health (NIPH) 177Lutetium-based peptide receptor radionuclide therapy for treating neuroendocrine tumours: a health technology assessment
2018     Norwegian Institute of Public Health (NIPH) Diagnostic accuracy, clinical effectiveness and budget impact of screening BRCA1/2 mutation carriers by MRI. A health technology assessment
2018     Norwegian Institute of Public Health (NIPH) Bariatric surgery for Type 2 Diabetes and a body mass index below 35
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Daratumumab (Darzalex®) in combination with bortezomib, melphalan and prednisone for untreated myeloma
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Re-orientation of the Austrian parent-child preventive care programme. Part XI: Further development of the mother-child-pass: Screening recommendations of the expert working group for pregnancy, puerperium and early childhood (0-6 years)
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Stereotactic radiotherapy, proton therapy and irreversible electroporation for the treatment of localised prostate cancer
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Endobronchial valve implantation for emphysema. Update 2018
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) High-intensity focused ultrasound for the treatment of prostate cancer. 1st Update 2018
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) (Percutaneous) left atrial appendage closure for the prevention of thromboembolic events in patients with atrial fibrillation. 3rd Update 2018
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Subcutaneous implantable cardioverter defibrillator (ICD)
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Lymphovenous anastomoses in patients with primary and secondary lymphoedema
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Allogeneic mesenchymal stem cells for Crohn’s disease-associated complex perianal fistulas
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Meniscal allograft transplantation for post-meniscectomy syndrome
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Baroreceptor activation therapy for treatment-resistant hypertension
2018     NIHR Health Technology Assessment programme The Patient Centred Assessment Method for improving nurse-led biopsychosocial assessment of patients with long-term conditions: a feasibility RCT
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Carbon ion beam radiotherapy (CIRT) for cancer treatment: a systematic review of effectiveness and safety for 12 oncologic indications
2018     NIHR Health Technology Assessment programme Multiple-frequency bioimpedance devices for fluid management in people with chronic kidney disease receiving dialysis: a systematic review and economic evaluation
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Nivolumab (Opdivo®) in combination with ipilimumab (Yervoy®) for the first-line treatment of patients with advanced RCC
2018     NIHR Health Technology Assessment programme Self-care support for children and adolescents with long-term conditions: the REfOCUS evidence synthesis
2018     NIHR Health Technology Assessment programme Therapy interventions for children with neurodisabilities: a qualitative scoping study
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Pembrolizumab (Keytruda®) in combination with chemotherapy for the treatment of metastatic non-small-cell lung cancer (NSCLC)
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Flashglucose monitoring system (Freestyle Libre, Abbott), report updated April 8 2020]
2018     NIHR Health Technology Assessment programme Axitinib, cabozantinib, everolimus, nivolumab, sunitinib and best supportive care in previously treated renal cell carcinoma: a systematic review and economic evaluation
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) External stimulation of the trigeminal nerve for the prevention and acute treatment of episodic and chronic migraine
2018     NIHR Health Technology Assessment programme The West Midlands ActiVe lifestyle and healthy Eating in School children (WAVES) study: a cluster randomised controlled trial testing the clinical effectiveness and cost-effectiveness of a multifaceted obesity prevention intervention programme targeted at children aged 6-7 years
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) PET/PET-CT Evidence for need based planning in Germany and Austria
2018     Center for Evidence-based Practice (CEP) Testing for clostridium difficile in oncology patients
2018     NIHR Health Technology Assessment programme Computerised interpretation of the fetal heart rate during labour: a randomised controlled trial (INFANT)
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Supporting children who have parents with mental disorders in Tyrol: A mapping of existing Tyrolean support and societal structures
2018     Center for Evidence-based Practice (CEP) Securement of Arterial Catheters
2018     NIHR Health Services and Delivery Research programme Predictive risk stratification model: a randomised stepped-wedge trial in primary care (PRISMATIC)
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Prevalence of mental disorders and uptake of mental health services in Tyrol: An analysis of epidemiological literature and administrative data from the Tyrolean health insurance
2018     Center for Evidence-based Practice (CEP) Guidance for Prostate Cancer Screening
2018     NIHR Health Services and Delivery Research programme Clinical leadership in service redesign using Clinical Commissioning Groups: a mixed-methods study
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Inhalation sedation with laughing gas (N2O) in dentistry – organisational and professional aspects and a systematic review of efficacy and safety
2018     Center for Evidence-based Practice (CEP) Risk Factors for Surgical Site Infection and Infection Prevention in Elective Spine Surgery
2018     NIHR Public Health Research (PHR) programme Cluster randomised controlled trial and economic and process evaluation to determine the effectiveness and cost effectiveness of a novel intervention [Healthy Lifestyles Programme (HeLP)] to prevent obesity in school children
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Drug reimbursement in the inpatient sector in Austria: Approaches for a transparent and evidence-based process, taking into account international experience
2018     Center for Evidence-based Practice (CEP) Venous Thromboembolism Prevention for Obese Patients
2018     NIHR Public Health Research (PHR) programme Collaborative case management to aid return to work after long-term sickness absence: a pilot randomised controlled trial
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Enzalutamide (Xtandi®) in patients with nonmetastatic, castration-resistant prostate cancer (CRPC)
2018     Center for Evidence-based Practice (CEP) Scales for Assessing Patients Receiving Moderate Sedation
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Ibrutinib (Imbruvica®) in combination with rituximab for the treatment of Waldenström’s macroglobulinaemia